Profiting from the Opioid Crisis

After raising their opioid overdose reversal drug 600%, drugmaker Kaleo released a statement claiming that profits haven’t driven their actions.

“We raised the price to improve access to this product. … The big misperception is that by raising the price of Evzio we reduce the access to this product.

Patients, not profits, have driven our actions.

Click here for article.